Allurion Technologies sees FY 24 revenue $60M – $65M

Anticipated procedural volume growth of approximately 20%, despite a reduction in overall marketing spend, reflecting increased penetration in key direct markets and reallocation of marketing spend to more efficient channels; Revenue guidance of $60 – $65 million, reflecting growth of approximately 13% – 23% year over year Expected gross margins of 77-79%, reflecting durable pricing of our gastric balloon as well as initial commercialization efforts of the digital platform;Targeted cash burn reduced to approximately $7 – $8M per quarter